Article Details

Aimmune Therapeutics (AIMT) Stock Rating Reaffirmed by Wedbush

Retrieved on: 2019-05-09 03:07:30

Tags for this article:

Click the tags to see associated articles and topics

Aimmune Therapeutics (AIMT) Stock Rating Reaffirmed by Wedbush. View article details on hiswai:

Excerpt

<div><b>Man Group plc</b> raised its stake in shares of Aimmune Therapeutics by 199.0% in the third quarter. <b>Man Group plc</b> now owns 16,550 shares of the ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up